MKMuhammad Saad Khan

Muhammad Saad Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Muhammad Saad Khan has a total of 197 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical versus non-surgical management of pediatric medial epicondyle fractures: a systematic review and meta-analysis

    by Humayou Ahmed, Aqsa, Erum Siddiqui, Kainat Mehmood, Maheen Hamid, Daniyal Zulfiqar, Muhammad Saad Khan, Nouraiz Abbas, Syed Ali Hassan, Waqas Ali, et al.

    Background: The optimal management of medial epicondyle fractures remains controversial, particularly in displaced fracture without incarceration. Traditionally, non-surgical treatment remains the treatment of choice for the management of medial epicondyle fracture; however recent evidence suggesting favorable outcomes with surgical fixation has increased interest in operative management. This systematic review and meta-analysis aimed to compare surgical versus non-surgical treatment for the management of medial epicondyle fracture in pediatric population to determine the optimal management therapy. Methods: A systematic search of PubMed, Cochrane Library, and Google Scholar and Clinical trial govt. was conducted from inception to April 2026 according to PRISMA guidelines (PROSPERO: CRD420261393871 ) . Randomized controlled trials and observational studies were included. Statistical analyses were performed using a random-effects model in RevMan 5.4. Risk of bias was evaluated using the Cochrane RoB 2 tool and Newcastle–Ottawa Scale, while certainty of evidence was assessed using GRADE. Results: Six comparative studies involving 564 pediatric patients were included, comprising two randomized controlled trials and four cohort studies. Surgical fixation significantly reduced the risk of non-union (RR = 0.09, 95% CI: 0.02–0.39; p = 0.001) and worse cosmetic VAS scores (MD = − 8.56, 95% CI: −12.66 to − 4.46; p < 0.0001), favoring non-surgical management. However, surgery was associated with a significantly greater likelihood of requiring additional surgery (RR = 13.37, 95% CI: 5.20–34.35; p < 0.00001). No significant differences were observed between groups for DASH scores, elbow flexion or extension deficits, PedsQL scores, or valgus instability tests. Conclusion: Surgical treatment reduces nonunion but is associated with worse cosmetic outcomes in pediatric medial epicondyle fracture. However, its effect on functional outcomes remains uncertain compared with non-surgical treatment. Treatment decisions should therefore be individualized based on clinical and patient-specific factors.

  • Open Access

    Dexamethasone versus triamcinolone acetonide for the management of postoperative inflammation following cataract surgery

    by Humayou Ahmed, Muhammad Saad Khan, Zauha Fawad Memon, Serish Bano, Samreen Shahid, Zainab Arif, Syed Ali Hassan, Umarah Lutuf, Wajeeha, Shifa, et al.

    Background: Cataract remains the leading cause of reversible blindness worldwide, particularly in low-resource settings. Effective control of postoperative inflammation is essential to prevent complications such as cystoid macular edema and raised intraocular pressure. Dexamethasone and Triamcinolone acetonide (TCA) are widely used corticosteroids; however, their comparative efficacy remains uncertain. This updated systematic review and meta-analysis aimed to compare their effectiveness following cataract surgery. Methods: A systematic search of 4 databases (PubMed, Google Scholar, Cochrane Central Library and Scopus) was conducted up to June 2026 following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (International Prospective Register of Systematic Reviews: CRD420261435380). Randomized controlled trials and prospective studies comparing dexamethasone and TCA in adults undergoing phacoemulsification were included. Risk of bias was assessed using cochrane risk of bias 2 and the Newcastle–Ottawa Scale. Certainty of evidence was evaluated using grading of recommendations assessment, development and evaluation. A random-effects model was used, with heterogeneity assessed by I 2 . Results: Twelve studies (nine randomized controlled trials and 3 non-randomized prospective studies; n = 2003) were included. No significant differences were observed in intraocular pressure (Mean Difference, mm Hg) at any time point up to 3 months. Visual acuity showed modest improvement with TCA at 7 and 28/30 days, though results were inconsistent on sensitivity analysis. No significant differences were found in anterior chamber flare or cells across all time points. A nonsignificant trend toward greater endothelial cell loss was observed with dexamethasone. Overall, evidence certainty was low. Conclusion: Dexamethasone and TCA demonstrate comparable efficacy and safety in controlling postoperative inflammation after cataract surgery. TCA may offer short-term visual benefits and prolonged action, whereas dexamethasone allows flexible dosing. Clinical decisions should be individualized, considering patient compliance and clinical context.

  • Effect of Temporary Methotrexate Discontinuation on Vaccine Immunogenicity and Disease Flare in Rheumatoid Arthritis: A Systematic Review

    by Ayesha Tahir, Ammara Iftikhar, Kashaw Kumar, Yusra Nawaz, Pakeeza Fatima, Muhammad Saeed, Shaheer Suhail Sarwar, Fatima Khalid, Ayesha Javaid, Bushra Akhtar, et al.

    Background: Methotrexate (MTX) is a cornerstone disease-modifying antirheumatic drug for rheumatoid arthritis (RA); however, it may attenuate vaccine-induced immune responses. Temporary MTX interruption around vaccination has been proposed to improve immunogenicity, but concerns remain regarding disease flare and safety. Objective: To evaluate whether temporary MTX discontinuation or delayed initiation around vaccination improves vaccine immunogenicity in adults with RA, while assessing its effects on disease activity, flare risk, and safety. Methods: PubMed/MEDLINE, Scopus, Embase, and Cochrane CENTRAL were searched for randomized controlled trials (RCTs) and observational studies comparing MTX continuation with temporary discontinuation or delayed initiation around vaccination in adults with RA. Outcomes included vaccine response rate, neutralizing antibody response, geometric mean antibody titers, disease activity, disease flare, and adverse events. Because of heterogeneity, findings were synthesized narratively. Results: Five studies were included: 4 RCTs and 1 retrospective observational cohort. Temporary MTX interruption or delayed initiation improved vaccine immunogenicity across influenza, COVID-19, and pneumococcal vaccines. The most consistent benefit was observed when MTX was withheld during the early post-vaccination period. Improved responses included higher seroconversion rates, increased neutralizing capacity, and antibody titers. Safety findings were generally acceptable, although repeated 2-week interruptions after closely spaced COVID-19 vaccine doses increased clinical disease activity index (CDAI)-defined flare rates in 1 trial. Risk-of-bias assessment suggested generally reliable evidence, with the observational cohort rated high quality and randomized trials largely showing low overall risk of bias. Conclusion and Relevance: Temporary MTX interruption, particularly after vaccination, may enhance vaccine immunogenicity in adults with RA. These findings provide clinically relevant evidence to guide MTX management around vaccination in adults with RA. However, this strategy should be individualized according to baseline disease activity, flare risk, vaccine type, and clinical context and should not be extrapolated to pediatric patients, for whom evidence was not identified in this review.

  • Open Access

    Prevalence of smartphone addiction and its association with anxiety and depression among pregnant women in Pakistan: A cross-sectional study

    by Laiba Akram, Muhammad Saad Khan, Erum Siddiqui, Nighat Shah, Marium Osama, Harshika Khaim Chandani, Umm e Abeeha Naqvi, Aminath Waafira

    Background: Excessive smartphone use has emerged as a growing public health concern and has been associated with anxiety, depression, and adverse behavioral outcomes. Although smartphone addiction (SA) has been widely studied in adolescents and young adults, limited evidence exists regarding its prevalence and psychological correlates among pregnant women, particularly in Pakistan, where perinatal anxiety and depression are highly prevalent. Objectives: To determine the prevalence of smartphone addiction risk among pregnant women and examine its association with anxiety, depression, and selected socio-demographic and gestational factors. Design: Observational analytical cross-sectional study. Methods: This study was conducted at the Department of Gynecology and Obstetrics, Jinnah Postgraduate Medical Centre, Karachi, from May to July 2025. A total of 350 pregnant smartphone users aged ≥18 years were recruited using consecutive sampling. Data were collected using a structured questionnaire, the Smartphone Addiction Scale–Short Version (SAS-SV), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). Descriptive statistics, chi-square tests, Pearson’s correlation, and multiple linear regression analyses were performed using SPSS version 25, with p < 0.05 considered significant. Results: High-risk smartphone addiction was identified in 3.5% (n = 12) of participants, while 96.5% were categorized as low risk. Anxiety and depression were significantly correlated with smartphone addiction. Multiple linear regression analysis showed that the overall model was statistically significant (R 2 = 0.088, F (7,342) = 4.691, p < 0.001). Anxiety (β = 0.237, p < 0.001) and level of education (β = 0.141, p = 0.010) were significant independent predictors of smartphone addiction. Conclusion: Although high-risk smartphone addiction was uncommon, higher smartphone addiction scores were associated with anxiety and depression. Anxiety emerged as the strongest independent predictor of smartphone addiction after adjustment for socio-demographic and obstetric factors. Integrating digital behavior screening with mental health assessment during antenatal care may help identify vulnerable women and support preventive interventions.

  • Open Access

    Carvedilol for prevention of cardiotoxicity in patients receiving anthracycline-based chemotherapy: a systematic review and meta-analysis

    by Kainat Mehmood, Syeda Masooma Jafri, Bareeha Haider, Shah Jahan, Aiza Ahsan, Ummama Qadeer, Muhammad Saad Khan, Muhammad Mohsin Khan, Kalpana Singh, Abubakr Mahmoud

  • Open Access

    Correlation of Echocardiographic Right Ventricular Functional Parameters with CMR-Derived Right Ventricular Ejection Fraction in Pulmonary Hypertension: A Systematic Review and Meta-Analysis

    by Faizan Ahmed, Ayesha Zulfiqar, Ramsha Ali, Syeda Simrah Shah, Saba Aliha, Muhammad Saad Khan, Sheraz Qasim, Maria Campwala, Maliha Khalid, Adiesh Sood, et al.

    Background: Pulmonary hypertension (PH) is associated with increased pulmonary arterial pressure and impairment of right ventricular (RV) function. Reliable characterization of RV performance is important for prognosis, risk assessment, and therapeutic planning. Cardiac magnetic resonance (CMR) is considered the reference technique for quantifying RV volumes and function, but its expense and limited availability can restrict routine implementation. Echocardiography is more widely accessible; however, the extent to which individual echocardiographic indices correspond with CMR-derived RV ejection fraction (RVEF) remains incompletely defined. Objective: Our objective was to determine the correlation of RV fractional area change (RV-FAC), RV free-wall longitudinal strain (RV-FWLS), and RV global longitudinal strain (RV-GLS) with CMR-derived RVEF in individuals with PH. Methods: PubMed, Embase, ClinicalTrials.gov, Scopus, and the Cochrane Library were searched, yielding 404 records; six studies fulfilled the eligibility criteria. Studies were eligible when they enrolled patients with PH and provided extractable correlations between at least one prespecified echocardiographic measure and CMR-derived RVEF. Correlation coefficients were converted with Fisher’s z transformation, combined using common-effect and random-effects approaches, and then transformed back to correlation coefficients. Pooled mean RV-FAC was evaluated as a separate outcome. Between-study heterogeneity was quantified with I2 and τ2, with random-effects estimates emphasized for interpretation. Results: Each evaluated echocardiographic measure was positively correlated with CMR-derived RVEF. RV-FWLS had the largest pooled correlation and the greatest consistency (r = 0.79, 95% CI: 0.73–0.83; I2 = 0.0%). The pooled correlation for RV-GLS was 0.75 (95% CI: 0.60–0.85; I2 = 80.3%), while that for RV-FAC was 0.72 (95% CI: 0.61–0.80; I2 = 61.8%). The random-effects pooled mean RV-FAC was 31.10% (95% CI: 26.77–35.43), with substantial heterogeneity (I2 = 90.9%). Conclusions: RV-FWLS showed the highest numerical and most consistent association with CMR-derived RVEF, suggesting that it may serve as a useful non-invasive adjunct for RV assessment in PH, especially where CMR is not readily available. Larger studies using harmonized acquisition and analysis methods are required for confirmation.

  • Efficacy and Safety of Linaclotide in Pediatric Patients of Functional Constipation: A Meta-analysis of Randomized Controlled Trials

    by Muhammad Saad Khan, Humayou Ahmed, Erum Siddiqui, Maliha Khalid, Devya Khaim Chandani, Hafiz Waqas Naseer, Muhammad Tarish Abro

    Objective: To evaluate the efficacy and safety of linaclotide in children with functional constipation (FC) by synthesizing evidence from randomized controlled trials (RCTs). Data Sources: A systematic search of PubMed, Scopus, Cochrane Central Register of Controlled Trials, and Google Scholar was conducted from inception through December 2024. The protocol was registered in PROSPERO (CRD420251018285), and the review was performed according to PRISMA guidelines. Study Selection and Data Extraction: RCTs comparing linaclotide with placebo in children (P = .0001) and reduction in straining (MD = −0.26, 95% CI, −0.42 to −0.10; P = .001). No significant effects were observed for spontaneous bowel movement frequency, complete spontaneous bowel movement frequency, or abdominal pain. Treatment-related adverse events were more frequent with linaclotide (relative risk [RR] = 2.93, 95% CI, 1.27-6.77), mainly due to increased diarrhea (RR = 3.81, 95% CI, 1.48-9.82). Relevance to Patient Care and Clinical Practice: Linaclotide may provide symptom relief for selected children with FC, particularly those with hard stools and straining despite conventional therapy. Clinicians should counsel families regarding diarrhea risk and monitor tolerability, while recognizing the limited long-term pediatric evidence. Conclusions: Linaclotide improves stool consistency and reduces straining in pediatric FC but does not consistently improve bowel frequency or global symptom resolution. Its safety profile is generally acceptable, although diarrhea is a notable adverse effect. Further long-term, independently funded trials are needed to define its optimal role in clinical practice.

  • Semaglutide and Other GLP-1 Agonists for Antipsychotic-Associated Metabolic Dysfunction in Schizophrenia

    by Nouraiz Abbas, Adil Ahmed Memon, Rumaisa Zulfiqar, Aqsa Zahoor Noon, Syed Mohamin Abbas Shah, Khadija Panhwar, Zehra Sadia, Muhammad Saad Khan, Muhammad Bilal Akbar, Sana Iftikhar, et al.

    Background: Individuals with schizophrenia spectrum disorders experience a high burden of metabolic abnormalities, which are further exacerbated by antipsychotic treatment and contribute to increased cardiovascular morbidity and premature mortality. Glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated metabolic benefits in the general population; however, their effectiveness and safety in individuals with schizophrenia remain uncertain. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials evaluating the effects of semaglutide and other GLP-1 receptor agonists on metabolic outcomes in adults with schizophrenia spectrum disorders receiving antipsychotic treatment. The review was conducted in accordance with PRISMA 2020 guidelines, with the protocol prospectively registered in PROSPERO (CRD420251248437). Electronic databases were searched from inception to the final search date. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool, and certainty of evidence was evaluated using the GRADE approach. Random-effects meta-analyses were performed. Results: Seven randomized controlled trials involving 446 participants were included. GLP-1 receptor agonist therapy was associated with a statistically significant reduction in body weight compared with control (−6.10 [95% CI: −12.10 to −0.10], P =0.05) although heterogeneity was substantial (I²=99%). Significant reductions were also observed in body mass index, waist circumference, and fasting plasma glucose. Effects on lipid parameters, insulin-related outcomes, and blood pressure were inconsistent and generally not statistically significant. Serious adverse events were less frequent in the intervention group. The certainty of evidence ranged from low to moderate, primarily due to heterogeneity and imprecision. Conclusions: GLP-1 receptor agonists are associated with statistically significant improvements in body weight and selected glycemic parameters among adults with schizophrenia spectrum disorders treated with antipsychotics. However, substantial heterogeneity, shorter study population, and low certainty of evidence restrict the strength of these conclusions. Larger, well-designed randomized controlled trials with longer follow-up and standardized outcome reporting are needed to better define the efficacy and safety of GLP-1 receptor agonists in this population.

  • Open Access

    Robotic vs laparoscopic left colectomy: a meta-analysis of over 70 000 patients across 24 trials

    by Shiza Abid, Kanza Farhan, Erum Siddiqui, Muhammad Saad Khan, Muhammad Burhan Tariq, Maliha Khalid, Cecille Nemeth, Mohammed Hammad Jaber Amin

    Background: Robotic platforms have slightly impacted minimally invasive surgery, although the extent of their superiority over conventional laparoscopy for left colectomy remains ambiguous. Robotic-assisted left colectomy (RLC) is increasingly utilized for the management of colorectal illnesses; nonetheless, there remains debate regarding its superiority over laparoscopic left colectomy (LLC). This meta-analysis integrates data from 24 studies, including over 70 000 people, to provide a comprehensive overview of the outcome disparities pre- and post-surgery. Methods: We conducted a comprehensive search of PubMed, Scopus, Web of Science, and Cochrane from 2004 to April 2025 to identify studies comparing RLC vs. LLC in adults. We utilized RevMan 5.4 to amalgamate the data. We employed random-effects models to determine the risk ratios (RRs) and mean differences (MDs). Sensitivity analysis was conducted to evaluate the robustness of the results amid increased heterogeneity. Results: A total of 24 investigations were conducted. RLC significantly reduced the likelihood of requiring open surgery (RR 0.53), experiencing postoperative complications (RR 0.87), encountering an anastomotic leak (RR 0.84), developing a superficial wound infection (RR 0.79), and necessitating additional surgery. The results were significantly more robust when high-variance trials were excluded from the sensitivity analysis. The duration of the procedure was significantly extended with RLC (MD + 40 minutes), although there were no changes in mortality (RR 1.26; P = 0.07) or hemorrhage (RR 1.00). No significant changes were observed in Clavien–Dindo >2 complications or stoma formation. Subgroup analysis was done for more robust findings. The asymmetry observed in the funnel plot suggests the potential existence of publication bias for certain outcomes. Conclusion: RLC demonstrates modest yet clinically significant advantages compared to LLC, particularly in reducing the incidence of surgical conversions and sequelae. These findings advocate for its application in a select group of patients, considering the duration of the treatment and the institution’s resources.

  • Open Access

    Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis

    by Muhammad Farhan, Syed Hassan Ali, Daniyal Khalid, Adina Kazmi, Dua Asim, Zoha Idrees, Muhammad Saim Siddiqui, Sudais Bin Sohaib, Muhammad Saad Khan, Muhammad Mohsin Khan, et al.

    Background: Peripheral artery disease (PAD) is a prevalent atherosclerotic disorder associated with significant cardiovascular morbidity. Although aspirin remains the cornerstone of therapy, residual thrombotic risk persists. The addition of rivaroxaban, a factor Xa inhibitor, may enhance protection through dual pathway inhibition. This meta-analysis aimed to evaluate the efficacy and safety of rivaroxaban plus aspirin versus aspirin alone in patients with PAD. Methods: A systematic review and meta-analysis were conducted following PRISMA and AMSTAR guidelines. Randomized controlled trials comparing rivaroxaban plus aspirin with aspirin alone in adults with PAD were included. Data were pooled using a random-effects model in Review Manager 5.4. Risk of bias was assessed with RoB 2 and certainty of evidence was graded using GRADE pro. Results: Six RCTs including 90 325 participants met inclusion criteria. Combination therapy significantly reduced MACE (RR: 0.82, 95% CI: 0.78–0.87), MI (RR: 0.87), ischemic stroke (RR: 0.76), and acute limb ischemia (RR: 0.68), with low heterogeneity (≤35%). No significant reduction was observed in cardiovascular mortality or major amputation. TIMI major bleeding risk increased (RR: 1.41, 95% CI: 1.07–1.84), however intracranial and fatal bleeding rates were similar between groups. Moderate-to-high certainty evidence supports reductions in ischemic and limb events, with increased bleeding risk. Conclusion: Rivaroxaban plus aspirin is associated with improved cardiovascular and limb outcomes compared to aspirin alone in PAD, albeit with a higher risk of major bleeding. Findings should be interpreted in the context of potential publication bias and heterogeneity across trials. Careful patient selection is warranted for optimal risk-benefit balance.